Skip to main content
. 2020 Nov 26;10(11):e038471. doi: 10.1136/bmjopen-2020-038471

Table 1.

Participant characteristics according to category of care at wave 1

Characteristic Category of TYA care at 12 months from diagnosis
NO-TYA-PTC
n=277
SOME-TYA-PTC
n=312
ALL-TYA-PTC
n=193
Age at diagnosis (years) Mean (SD) 21.04 (3.01) 19.40 (3.41) 19.97 (3.15)
Age groups 13 to 15 years 37 (10%) 72 (17%) 40 (15%)
16 to 18 years 34 (10%) 128 (31%) 78 (29%)
19 to 24 years 288 (80%) 215 (52%) 152 (56%)
Gender Male 148 (53%) 165 (53%) 112 (58%)
Female 129 (47%) 147 (47%) 81 (42%)
Ethnicity* White 252 (91%) 273 (88%) 163 (84%)
Mixed 4 (1%) 5 (2%) 4 (2%)
Asian 15 (5%) 24 (8%) 20 (10%)
Black 4 (1%) 7 (2%) 2 (1%)
Other 2 (1%) 3 (1%) 4 (2%)
Socioeconomic status (IMD quintile) 1 – most deprived 66 (24%) 73 (24%) 34 (18%)
2 47 (17%) 52 (17%) 32 (17%)
3 51 (19%) 60 (20%) 37 (20%)
4 65 (24%) 61 (20%) 40 (21%)
5 – least deprived 46 (17%) 59 (19%) 46 (24%)
Marital Status Married/civil partnership 9 (4%) 8 (3%) 6 (3%)
Cohabiting 43 (17%) 27 (10%) 18 (10%)
Single/divorced 198 (79%) 227 (87%) 148 (86%)
Current status Working full-time/part-time 126 (45%) 72 (23%) 43 (22%)
In education 61 (22%) 112 (36%) 81 (42%)
Other work (apprentice/intern/voluntary) 6 (2%) 5 (2%) 6 (3%)
Unemployed 10 (4%) 11 (4%) 7 (4%)
Long-term sick 39 (14%) 51 (16%) 31 (16%)
Not seeking work 35 (13%) 61 (20%) 25 (13%)
Type of cancer (Birch classification) Leukaemia 19 (7%) 49 (16%) 33 (17%)
Lymphoma 111 (40%) 75 (24%) 70 (36%)
CNS 9 (3%) 9 (3%) 12 (6%)
Bone 7 (3%) 59 (19%) 3 (2%)
Sarcomas 8 (3%) 31 (10%) 15 (8%)
Germ cell 64 (19%) 55 (18%) 31 (16%)
Skin 22 (8%) 1 (<1%) 4 (2%)
Carcinomas (not skin) 41 (15%) 31 (10%) 23 (12%)
Miscellaneous specified† 5 (2%) 2 (<1%) 1 (<1%)
Unspecified malignant 1 (<1%) 0 1 (<1%)
Severity at diagnosis
(row %, column %) Least 200 (46% to 72%) 133 (31% to 43%) 95 (22% to 49%)
Intermediate 49 (26% to 18%) 82 (44% to 26%) 56 (30% to 29%)
Most 28 (17% to 10%) 97 (58% to 31%) 42 (25% to 22%)
Prognostic score <50% 21 (8%) 60 (19%) 41 (21%)
50% to 80% 54 (20%) 125 (40%) 44 (23%)
>80% 200 (73%) 126 (41%) 108 (56%)
Location‡ Birmingham 41 (15%) 59 (19%) 12 (6%)
Bristol 51 (18%) 32 (10%) 4 (2%)
Cambridge 12 (4%) 8 (3%) 1 (1%)
Manchester 22 (8%) 35 (11%) 11 (6%)
Merseyside 13 (5%) 11 (4%) 6 (3%)
East Midlands 15 (5%) 24 (8%) 60 (31%)
Leeds 20 (7%) 25 (8%) 25 (13%)
Newcastle 13 (5%) 6 (2%) 24 (12%)
Oxford 5 (2%) 4 (1%) 7 (4%)
London 60 (22%) 83 (27%) 10 (5%)
Sheffield 7 (3%) 9 (3%) 9 (5%)
Southampton 18 (7%) 16 (5%) 24 (12%)
Given a choice about where to receive treatment§ n=272 n=311 n=192
Yes 121 (45%) 86 (28%) 48 (25%)
No (or <19 years) 151 (56%) 225 (72%) 144 (75%)
Long-term condition prior to cancer n=277 n=311 n=193
Yes 20 (7%) 34 (11%) 18 (9%)
No 257 (93%) 277 (89%) 175 (91%)
Time to diagnosis: days from first symptom Median (IQR), (min, max) n=264 n=304 n=188
62 (29.5 to 168.5)
(0 to 1340)
65.5 (29.5 to 152.5)
(0 to 959)
63.5 (25.5 to 151.0)
(0 to 1217)
Time to diagnosis: number of GP visits before diagnosis Median (IQR), (min, max) n=274 n=311 n=193
1 (0 to 3)
(0 to 20)
1 (0 to 3)
(0 to 20)
2 (1 to 3)
(0 to 40)

*Wave 1 data was used with missing values completed using available Public Health England data.

†Includes 4 ‘unclassified’ – treated in cancer unit but did not have cancer

‡Those <19 years at diagnosis were assumed not to have been given a choice

§Includes the TYA-PTC and hospitals linked to the multidisciplinary team at the TYA-PTC; where available based on hospital of diagnosis, for 77 cases based on recruiting hospital

CNS, central nervous system; GP, general practitioner; IMD, index of multiple deprivation; TYA, teenagers and young adults; TYA-PTC, TYA principal treatment centres.